Vol.:(0123456789) 1 3
Journal of Neural Transmission
https://doi.org/10.1007/s00702-018-1963-4
NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - ORIGINAL ARTICLE
Acute and chronic methylphenidate administration in intact and VTA-
specifc and nonspecifc lesioned rats
Stephanie A. Ihezie
1
· Ming M. Thomas
1
· Nachum Dafny
1
Received: 6 August 2018 / Accepted: 7 December 2018
© Springer-Verlag GmbH Austria, part of Springer Nature 2019
Abstract
Methylphenidate (MPD) is a psychostimulant used for the treatment of ADHD and works by increasing the bioavailability
of dopamine (DA) in the brain. As a major source of DA, the ventral tegmental area (VTA) served as the principal target in
this study as we aimed to understand its role in modulating the acute and chronic MPD efect. Forty-eight male Sprague–
Dawley rats were divided into control, sham, electrical lesion, and 6-OHDA lesion groups. Given the VTA’s implication in
the locomotive circuit, three locomotor indices—horizontal activity, number of stereotypy, and total distance—were used
to measure the animals’ behavioral response to the drug. Baseline recording was obtained on experimental day 1 (ED 1)
followed by surgery on ED 2. After recovery, the behavioral recordings were resumed on ED 8. All groups received daily
intraperitoneal injections of 2.5 mg/kg MPD for six days after which the animals received no treatment for 3 days. On ED
18, 2.5 mg/kg MPD was re-administered to assess for the chronic efect of the psychostimulant. Except for one index, there
was an increase in locomotive activity in all experimental groups after surgery (in comparison to baseline activity), acute
MPD exposure, induction with six daily doses, and after MPD re-challenge. Furthermore, the increase was greatest in the
electrical VTA lesion group and lowest in the 6-OHDA VTA lesion group. In conclusion, the results of this study suggest
that the VTA may not be the primary nucleus of MPD action, and the VTA plays an inhibitory role in the locomotive circuit.
Keywords Behavior · Locomotion · Ritalin · CNS lesion · Psychostimulant · Sensitization
Introduction
Psychostimulants have historically been used in the treat-
ment of Attention Defcit Hyperactivity Disorder (ADHD),
a behavioral disorder linked to low dopamine activity in the
brain (Kalivas 1993). Methylphenidate (MPD, Ritalin) has
become the pharmacotherapy of choice for ADHD (Chall-
man and Lipsky 2000; Swanson et al. 1991) since it indi-
rectly increases levels of dopamine (DA) and norepinephrine
(NE) by inhibiting their reuptake from the presynaptic cleft.
A major source of dopamine in the rat midbrain is the
A10 cells of the ventral tegmental area (VTA) which serve
as the origin of the dopaminergic mesolimbic pathway
(German and Manaye 1993; Kelly et al. 1975). Within the
VTA there are GABAergic, glutamatergic, and dopamin-
ergic neurons—mainly D1 DA which are excitatory and
D2 DA which are inhibitory (Nair-Roberts et al. 2008;
Olson and Nestler 2007; Ranaldi and Wise 2001). The
glutamatergic aferents to the VTA originate from prefron-
tal cortex (PFC) primarily but also from the subthalamic
nucleus, the pedunculopontine- and laterodorsal-tegmen-
tal nuclei, the bed nucleus of the stria terminalis, and the
superior colliculus (Morikawa and Paladini 2011; Kita
and Kitai 1987; Clements et al. 1991; Lavoie and Parent
1994; Charara et al. 1996; Georges and Aston-Jones 2002;
Comoli et al. 2003; Dommett et al. 2005). The GABAergic
aferents come from the nucleus accumbens (NAc), ventral
pallidum, and rostromedial tegmental nucleus (Morikawa
and Paladini 2011). As for output, the two major eferents
from the VTA project back to the PFC and NAc though
there are also projections to the amygdala, cingulate gyrus,
hippocampus, and olfactory bulb (Malenka et al. 2009;
Nechifor 2008). Given the heterogeneity in VTA com-
position and connections, the outcome of glutamatergic
inputs are not exclusively excitatory nor are the outcome
* Nachum Dafny
nachum.dafny@uth.tmc.edu
1
Department of Neurobiology and Anatomy, University
of Texas Health Science Center at Houston, McGovern
Medical School, 6431 Fannin Street, Houston, TX 77030,
USA